IndraLab

Statements

Ruxolitinib inhibits JAK1-T901A. 1 / 1

| 1

reach

"Ruxolitinib blocked IL7R downstream signaling in both IL7R RFCPH and JAK1 T901A lines, but was ineffective in blocking signaling in AKT or NRAS lines, as expected (Figs XREF_FIG and XREF_SUPPLEMENTARY)."

27997540

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Ruxolitinib inhibits JAK1-T901A. 1 / 1

INDRA sources:

Databases

Reading